Electro Cable Egypt (EGX:ELEC)
Egypt · Delayed Price · Currency is EGP 2.780
0.00 (0.00%)
At close: Aug 5, 2025
CTI BioPharma Cash Flow Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 1,244 | 1,328 | 1,248 | 542.25 | 224.63 | 133.51 | Upgrade |
Depreciation & Amortization | 48.61 | 47.88 | 40.68 | 32.15 | 21.06 | 18.74 | Upgrade |
Loss (Gain) From Sale of Assets | -0.18 | -0.18 | -4.28 | -0.28 | -78.22 | -98.02 | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | - | -2.19 | Upgrade |
Loss (Gain) From Sale of Investments | -1.24 | -1.28 | -0.97 | -0.87 | - | - | Upgrade |
Loss (Gain) on Equity Investments | 1.93 | 4.14 | 5.87 | 4.87 | - | - | Upgrade |
Provision & Write-off of Bad Debts | 91.77 | 83.42 | 35.9 | 12.87 | 7.45 | - | Upgrade |
Other Operating Activities | 2,381 | 2,113 | 1,037 | 315.69 | 139.26 | 85.98 | Upgrade |
Change in Accounts Receivable | -5,971 | -4,471 | -2,577 | -189.11 | -607.79 | -379.71 | Upgrade |
Change in Inventory | -1,053 | -1,776 | -337.99 | -609.03 | -538.58 | -142.41 | Upgrade |
Change in Accounts Payable | 127.79 | -183.12 | 247.67 | -49.54 | 247.7 | 249.12 | Upgrade |
Change in Income Taxes | -309.32 | -293.07 | -151.77 | -29.93 | -41.71 | -59.12 | Upgrade |
Change in Other Net Operating Assets | -36.47 | -36.99 | -9.17 | -6.46 | -4.43 | -4.76 | Upgrade |
Operating Cash Flow | -3,658 | -3,323 | -493.21 | 22.1 | -641.23 | -213.1 | Upgrade |
Capital Expenditures | -149.76 | -213.07 | -88.47 | -215.08 | -65.58 | -19.25 | Upgrade |
Sale of Property, Plant & Equipment | 2.98 | 2.98 | 31.18 | 0.92 | 103.91 | 105.68 | Upgrade |
Cash Acquisitions | -37.63 | -37.63 | - | - | - | - | Upgrade |
Investment in Securities | 69.51 | 119.04 | -425.72 | -91.14 | 50.94 | 31.39 | Upgrade |
Other Investing Activities | 56.8 | 53.77 | 50.47 | 17.07 | 7.45 | 7.26 | Upgrade |
Investing Cash Flow | -58.09 | -74.91 | -432.55 | -288.23 | 96.72 | 125.07 | Upgrade |
Short-Term Debt Issued | - | 4,930 | 2,044 | 793.35 | 604.06 | 281.6 | Upgrade |
Long-Term Debt Issued | - | 20.57 | 306.07 | 209.78 | 55.22 | - | Upgrade |
Total Debt Issued | 5,635 | 4,951 | 2,350 | 1,003 | 659.28 | 281.6 | Upgrade |
Long-Term Debt Repaid | - | - | -42.67 | -72.2 | -84.93 | -24.65 | Upgrade |
Total Debt Repaid | 14.61 | - | -42.67 | -72.2 | -84.93 | -24.65 | Upgrade |
Net Debt Issued (Repaid) | 5,650 | 4,951 | 2,307 | 930.93 | 574.35 | 256.96 | Upgrade |
Issuance of Common Stock | - | - | - | - | 53.24 | - | Upgrade |
Repurchase of Common Stock | - | - | -52.27 | -42.16 | -14.19 | -21.12 | Upgrade |
Common Dividends Paid | -175.09 | -164.9 | -68.58 | -36.69 | -21.06 | -30.43 | Upgrade |
Other Financing Activities | -2,075 | -1,789 | -634.18 | -175.43 | -72.89 | -53.01 | Upgrade |
Financing Cash Flow | 3,399 | 2,996 | 1,552 | 676.65 | 519.45 | 152.4 | Upgrade |
Foreign Exchange Rate Adjustments | 48.3 | 69.34 | -35 | -10.5 | 3.78 | 2.26 | Upgrade |
Net Cash Flow | -268.12 | -331.76 | 591.44 | 400.02 | -21.28 | 66.64 | Upgrade |
Free Cash Flow | -3,808 | -3,536 | -581.68 | -192.99 | -706.81 | -232.34 | Upgrade |
Free Cash Flow Margin | -26.39% | -25.66% | -6.71% | -3.39% | -26.56% | -13.35% | Upgrade |
Free Cash Flow Per Share | -1.15 | -1.07 | -0.17 | -0.06 | -0.20 | -0.07 | Upgrade |
Cash Interest Paid | 2,075 | 1,789 | 634.18 | 176.28 | - | - | Upgrade |
Levered Free Cash Flow | -6,022 | -5,183 | -1,430 | -350.69 | -796.43 | -277.51 | Upgrade |
Unlevered Free Cash Flow | -4,725 | -4,065 | -1,033 | -240.51 | -750.87 | -244.38 | Upgrade |
Change in Net Working Capital | 6,889 | 6,052 | 2,411 | 593.33 | 883.95 | 319.85 | Upgrade |
Updated Nov 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.